Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 2—February 2004
THEME ISSUE
2004 SARS Edition
SARS Epidemiology

SARS Surveillance during Emergency Public Health Response, United States, March–July 2003

Stephanie J. Schrag*Comments to Author , John T. Brooks*, Chris Van Beneden*, Umesh D. Parashar*, Patricia M. Griffin*, Larry J. Anderson*, William J. Bellini*, Robert F. Benson*, Dean D. Erdman*, Alexander Klimov*, Thomas G. Ksiazek*, Teresa C.T. Peret*, Deborah F. Talkington*, W. Lanier Thacker*, Maria L. Tondella*, Jacquelyn S. Sampson*, Allen W. Hightower*, Dale F. Nordenberg*, Brian D. Plikaytis*, Ali S. Khan*, Nancy E. Rosenstein*, Tracee A. Treadwell*, Cynthia G. Whitney*, Anthony E. Fiore*, Tonji M. Durant*, Joseph F. Perz*, Annemarie Wasley*, Daniel R. Feikin*, Joy L. Herndon*, William A. Bower*, Barbara W. Kilbourn*, Deborah A. Levy*, Victor G. Coronado*, Joanna Buffington*, Clare A. Dykewicz*, Rima F. Khabbaz*, and Mary E. Chamberland*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 5

Results of diagnostic testing for other infectious respiratory pathogens, U.S. SARS surveillance, March–July, 2003a,b,c

SARS-CoV status Mycoplasma pneumoniae Streptococcus pneumoniae Chlamydia pneumoniaed Legionella pneumophila HMPV Influenza A or B Parainfluenza 1, 2, or 3 RSV Adenovirus Picornaviruse
Positive
Chest imaging resultsf positive 0/2
(0%) 0/1
(0%) 0/2
(0%) 0/2
(0%) 0/1
(0%) 1/1
(100%) 0/1
(0%) 0/1
(0%) 0/1
(0%) --
Negative
Chest imaging results positive 3/24
(13%) 0/16
(0%) 0/24
(0%) 0/24
(0%) 2/22
(9%) 0/21
(0%) 1/22
(5%) 0/22
(0%) 0/22
(0%) 3/10
(30%)
Chest imaging results negative 11/99
(11%) 5/71
(7%) 2/95
(2%) 0/96
(0%) 8/90
(9%) 16/84
(19%) 5/90
(6%) 2/90
(2%) 5/90
(6%) 12/45
(27%)
Undetermined
Chest imaging results positive 3/14
(21%) 1/1
(100%) 0/15
(0%) 0/14
(0%) 1/13
(8%) 1/13
(8%) 2/13
(15%) 0/13
(0%) 1/13
(8%) 4/13
(31%)
Chest imaging results negative 5/61
(8%) 0/1
(0%) 0/61
(0%) 0/60
(0%) 1/47
(2%) 7/47
(15%) 4/47
(9%) 1/47
(2%) 3/47
(6%) 10/46
(22%)











Totals 22/200
(11%) 6/90
(7%) 2/197
(1%) 0/196
(0%) 12/172
(7%) 25/166 (15%) 12/172
(7%) 3/172
(2%) 9/172
(5%) 29/114
(25%)

aSARS, severe acute respiratory syndrome; CoV, coronavirus; HMPV, human metapneumovirus; RSV, respiratory syncytial virus; PCR, polymerase chain reaction.

bDenominators for results of tests vary as specimens of appropriate type and of adequate amount necessary for PCR and serologic testing were obtained only for a subset of case-patients. Positive results shown are those persons for whom evidence of acute infection was demonstrated by serologic and/or PCR testing on the specimens available for testing.

cOnly one of the two SARS-CoV–positive case-patients had evidence of infection with another agent (influenza B). For 22 suspect and probable cases, more than one agent was identified. Combinations included: HMPV, Influenza B (FluB) + S. pneumoniae (N = 1); Mycoplasma, picornavirus + S. pneumoniae (N = 1); Mycoplasma + FluA (N = 5); HMPV + parainfluenza virus (HPIV) (N = 1); C. pneumoniae, adenovirus + FluB (N = 1); Mycoplasma + picornavirus (N = 3); adenovirus + picornavirus (N = 1); Mycoplasma + HPIV (N = 1); HPIV + picornavirus (N = 1); FluB + picornavirus (N = 1); adenovirus + HMPV (N = 1); HPIV + picornavirus (N = 1); HMPV + picornavirus (N = 1); Mycoplasma + picornavirus (N = 1); S. pneumoniae + picornavirus (N = 1); S. pneumoniae + HMPV (N = 1).

dAll specimens tested for serologic or PCR evidence of C. pneumoniae were also tested for evidence of C. psittaci; no acute C. psittaci infections were diagnosed.

eInclusive of rhinovirus and enterovirus.

fPlain film x-ray, computed tomographic scan, etc.

Main Article

Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external